Citigroup Reduces $6M in Acadia Healthcare Company, Inc. ($ACHC)
Key Points
- Citigroup changed its Acadia Healthcare Company, Inc. ($ACHC) stake by 8.6% last quarter, cutting to 2,352,318 shares worth $58.55 million.
- Wall Street's consensus rating on $ACHC is Buy and an average price target of $28.86.
- $ACHC last traded around $24.89.
Citigroup trimmed its position in Acadia Healthcare Company, Inc. ($ACHC) by 8.6% during the most recent quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,352,318 shares of Acadia Healthcare Company, Inc. after selling 222,622 shares during the quarter. Citigroup's holdings in Acadia Healthcare Company, Inc. were worth $58.55 million as of its most recent filing.
Acadia Healthcare Company, Inc. ($ACHC) Stock
Acadia Healthcare Company, Inc. Earnings
Analysts Set New Price Targets
About Acadia Healthcare Company, Inc.
Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company owns and operates acute inpatient psychiatric facilities; specialty treatment facilities comprising residential recovery facilities and eating disorder facilities; comprehensive treatment centers; and residential treatment centers, as well as facilities providing outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities. Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee.
See Also
This instant news alert was generated by automated narrative technology and financial data from Opentrades and public regulatory filings. It is for informational purposes only and is not financial advice.